In vivo assessment of NS1-truncated influenza virus with a novel SLSYSINWRH motif as a self-adjuvanting live attenuated vaccine

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Ngunjiri, John M ^a,b   Ali, Ahmed ^c,d   Boyaka, Prosper ^b   Marcus, Philip I ^a   Lee, Chang Won ^b,d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Beni Suef University   (Egypt)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INTERFERON; NONSTRUCTURAL PROTEIN 1; INS1 PROTEIN, INFLUENZA VIRUS; PRIMER DNA; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG EFFICACY; HETEROLOGOUS IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFLUENZA; INFLUENZA A; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H7N2; INFLUENZA VIRUS A H7N3; INTERFERON INDUCTION; MOUSE; NONHUMAN; PREDICTION; PROTEIN MOTIF; QUANTITATIVE ANALYSIS; SEROCONVERSION; SWINE; TREATMENT OUTCOME; VIRUS SHEDDING; VIRUS STRAIN; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MUTAGENESIS; ORTHOMYXOVIRIDAE; PIG; PROCEDURES; PROTEIN ENGINEERING;

GALLUS GALLUS; MAMMALIA; MURINAE; MUS; ORTHOMYXOVIRIDAE; SUIDAE;

AMINO ACID MOTIFS; ANALYSIS OF VARIANCE; ANIMALS; DNA PRIMERS; IN VITRO TECHNIQUES; INFLUENZA VACCINES; INTERFERON TYPE I; MICE; MUTAGENESIS; ORTHOMYXOVIRIDAE; PROTEIN ENGINEERING; SWINE; VIRAL NONSTRUCTURAL PROTEINS; VIRUS SHEDDING;

EID: 84926330910     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118934     Document Type: Article

References (49)

1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007; 25:5086-5096. PMID: 17544181
2. Bean WJ, Kawaoka Y, Wood JM, Pearson JE, Webster RG. Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol. 1985; 54: 151-160. PMID: 3973976
3. Capua I, Mutinelli F, Pozza MD, Donatelli I, Puzelli S, Cancellotti FM. The 1999-2000 avian influenza (H7N1) epidemic in Italy: veterinary and human health implications. Acta Trop. 2002; 83:7-11. PMID: 12062787
4. Cyranoski D. Outbreak of chicken flu rattles Hong Kong. Nature. 2001; 412:261. PMID: 11460125
5. Fouchier RAM, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SAG, Munster C, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA. 2004; 101:1356-1361. PMID: 14745020
6. Van Reeth K, Ma W. Swine Influenza Virus Vaccines: To Change or Not to Change-That's the Question. Curr Top Microbiol Immunol. 2012; 370:173-200. doi: 10.1007/82-2012-266 PMID: 22976350
7. Vincent AL, Ma W, Lager KM, Janke BH, Richt JA. Swine influenza viruses a North American perspective. Adv Virus Res. 2008; 72:127-54. doi: 10.1016/S0065-3527(08)00403-X PMID: 19081490
8. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005; 353: 1374-1385. PMID: 16192482
9. Neumann G, Kawaoka Y. The first influenza pandemic of the new millennium. Influenza Other Respi Viruses. 2011; 5(3):157-66. doi: 10.1111/j.1750-2659.2011.00231.x PMID: 21477134
10. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 2012; 12:36-44. doi: 10.1016/S1473-3099(11)70295-X PMID: 22032844
11. Gorse GJ, Campbell MJ, Otto EE, Powers DC, Chambers GW, Newman FK. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J. Infect. Dis. 1995; 172:1-10. PMID: 7797897
12. LaMere MW, Lam HT, Moquin A, Haynes L, Lund FE, Randall TD, et al. Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J. Immunol. 2011; 186:4331-4339. doi: 10.4049/jimmunol.1003057 PMID: 21357542
13. Nelson KM, Schram BR, McGregor MW, Sheoran AS, Olsen CW, Lunn DP. Local and systemic iso-type-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine. 1998; 16:1306-1313. PMID: 9682395
14. Powell TJ, Strutt T, Reome J, Hollenbaugh JA, Roberts AD, Woodland DL, et al. Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus. J. Immunol. 2007; 178:1030-1038. PMID: 17202366
15. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. 1 A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994; 169: 68-76. PMID: 8277200
16. Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med, 2006; 355: 2513-2522. PMID: 17167134
17. Richt JA, García-Sastre A. Attenuated influenza virus vaccines with modified NS1 proteins. Curr. Top. Microbiol. Immunol. 2009; 333:177-195. doi: 10.1007/978-3-540-92165-3-9 PMID: 19768406
18. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, Ruggli N, et al. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol. 2007; 88:1403-1409. PMID: 17412966
19. Martínez-Sobrido L, Lienenklaus S, Weiss S, García-Sastre A, Staeheli P. Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J. Gen. Virol. 2009; 90:2990-2994. doi: 10.1099/vir.0.015727-0 PMID: 19726611
20. Marcus PI, Rojek JM, Sekellick MJ. Interferon induction and/or production and its suppression in influenza viruses. J Virol. 2005; 79:2880-2890. PMID: 15709007
21. Marcus PI, Ngunjiri JM, Sekellick MJ, Wang L, Lee CW. In Vitro Analysis of Virus Particle Subpopulations in Candidate Live-Attenuated Influenza Vaccines Distinguishes Effective from Ineffective Vaccines. J Virol. 2010; 84: 10974-10981. doi: 10.1128/JVI.00502-10 PMID: 20739541
22. Ngunjiri JM, Lee CW, Ali A, Marcus PI. Influenza virus interferon-inducing particle efficiency is reversed in avian and mammalian cells, and enhanced in cells co-infected with defective-interfering particles. J. Interferon Cytokine Res. 2012; 32:280-285. doi: 10.1089/jir.2011.0102 PMID: 22385205
23. Quinlivan M, Zamarin D, García-Sastre A, Cullinane A, Chambers T, Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 2005; 79:8431-8439 PMID: 15956587
24. Solórzano A, Webby RJ, Lager KM, Janke BH, García-Sastre A, Richt JA. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 2005; 79:7535-7543 PMID: 15919908
25. Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol. 2009; 83:1742-1753. doi: 10.1128/JVI.01920-08 PMID: 19073731
26. Wang X, Basler CF, Williams BRG, Silverman RH, Palese P, García-Sastre A. Functional replacement of the carboxy-terminal two thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol 2002; 76:12951-12962 PMID: 12438621
27. Ngunjiri JM, Mohni KN, Sekellick MJ, Schultz-Cherry S, Webster RG, Marcus PI. Lethal H5N1 influenza viruses are not resistant to interferon action in human, simian, porcine, or chicken cells. Nature Med. 2012; 18:1456-1457. doi: 10.1038/nm.2879 PMID: 23042343
28. Bracci L, Canini I, Venditti M, Spada M, Puzelli S, Donatelli I, et al. Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus. Vaccine. 2006 24(Suppl. 2):56-57 PMID: 16823927
29. Bracci L, Canini I, Puzelli S, Sestili P, Venditti M, Spada M, et al. Type I interferon is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level. Vaccine 2005; 23:2994-3004. PMID: 15811645
30. Le Bon A, Tough DF. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol. 2002; 14: 432-436. PMID: 12088676
31. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 2001; 14: 461. PMID: 11336691
32. Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol. 2003; 4:1009-1015. PMID: 14502286
33. Le Bon A, Durand V, Kamphuis E, Thompson C, Bulfone-Paus S, Rossmann C. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol. 2006; 176: 4682-4689. PMID: 16585561
34. Mueller SN, Langley WA, Carnero E, García-Sastre A, Ahmed R. Immunization with live-attenuated influenza viruses expressing altered NS1 proteins results in potent and protective memory CD8+ T cells responses. J Virol. 2010; 84:1847-1855. doi: 10.1128/JVI.01317-09 PMID: 19939929
35. Nagao Y, Yamashiro K, Hara N, Horisawa Y, Kato K, Uemura A. Oral-mucosal administration of IFN-α potentiates immune response in mice. J. Interferon Cytokine Res. 1998; 18:661-666. PMID: 9781804
36. Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, De Vincenzi E, et al. Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J Immunol. 2002; 169: 375-383. PMID: 12077267
37. Staats HF, Bradney CP, Gwinn WM, Jackson SS, Sempowski GD, Liao HX, et al. Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J. Immunol. 2001; 167:5386-5394. PMID: 11673557
38. Wang L, Suarez DL, Pantin-Jackwood M, Mibayashi M, García-Sastre A, Saif YM, et al. Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine. 2008; 26:3580-3586. doi: 10.1016/j.vaccine.2008.05.001 PMID: 18539366
39. Ali A, Daniels JB, Zhang Y, Rodriguez-Palacios A, Hayes-Ozello K, Mathes L, et al. Pandemic and seasonal human influenza virus infections in domestic cats: prevalence, association with respiratory disease, and seasonality patterns. J Clin Microbiol. 2011; 49:4101-4105. doi: 10.1128/JCM.05415-11 PMID: 21956989
40. Lee CW. Reverse genetics of the avian influenza virus. Methods Mol Biol. 2014; 1161:37-50 doi: 10.1007/978-1-4939-0758-8-4 PMID: 24899418
41. Tang Y, Lee CW, Zhang Y, Senne DA, Dearth R, Byrum B, et al. Isolation and characterization of H3N2 influenza A virus from turkeys. Avian Dis. 2005; 49(2):207-13. PMID: 16094824
42. Marcus PI, Ngunjiri JM, Sekellick MJ. Dynamics of Biologically Active Sub-populations of Influenza Virus: Plaque-Forming, Noninfectious Cell-Killing, and Defective-Interfering Particles. J Virol. 2009; 83:8122-8130. doi: 10.1128/JVI.02680-08 PMID: 19494019
43. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol. 2001; 69: 912-920 PMID: 11404376
44. García-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998; 252:324-330. PMID: 9878611
45. Palese P, García-Sastre A. Influenza vaccines: present and future. J Clin Invest. 2002; 110(1):9-13. PMID: 12093881
46. Ayllon J, Russell RJ, Garcia-Sastre A, Hale BG. Contribution of NS1 effector domain dimerization to influenza A virus replication and virulence. J. Virol. 2012; 86:13095-13098. doi: 10.1128/JVI.02237-12 PMID: 22993153
47. Bornholdt ZA, Prasad BV. X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature. 2008; 456:985-988. doi: 10.1038/nature07444 PMID: 18987632
48. Nemeroff ME, Qian XY, Krug RM. The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology. 1995; 212:422-428. PMID: 7571411
49. Salvatore M, Basler CF, Parisien JP, Horvath CM, Bourmakina S, Zheng H, et al. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol. 2002; 76:1206-1212. PMID: 11773396